2021 healthcare M&A on the rise
Continuous employee turnover indicates long-term staffing concerns
U.S. hospitals and healthcare facilities alike have witnessed employees resign for a variety of reasons, creating a surge in demand for healthcare workers coupled with an increase in average wage and salary. This confluence of COVID-driven market conditions is responsible for the significant growth in the healthcare staffing space over the last 12 months, with long-term implications anticipated for 2022 and beyond.
M&A overview
There were 923 reported M&A transactions that closed during the second half of 2021, up from the 872 transactions during H2 2020. Reported closed transactions in H2 2021 increased 25% compared to 185 closed deals for the same period in 2020.
The aggregate deal value of the closed M&A transactions with reported values was $213.1 billion during H2 2021. This was a significant increase from the total reported deal value of $110.6 billion in H1 2021, driven by an increase in both average deal size and deal volumes. Of note, a greater number of deals reported transaction values during the period.
One particular acquisition, in July 2021, accounted for a substantial portion of the increase: AstraZeneca PLC’s (LSE:AZN) $43.4 billion acquisition of Alexion Pharmaceuticals, Inc.
Quarterly U.S. healthcare M&A activity for transactions closed.
Aggregate transaction value and number of deals.
Source: S&P Capital IQ
32 revenue multiples reported in both Q3 2021 and Q4 2021

